BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 2428786)

  • 1. Comparison of HLA-Dw1 and -Dw2 positive adherent cells in antigen presentation to heterozygous T-cell lines: a low rubella antigen-specific response associated with HLA-Dw2.
    Ilonen J; Salmi A
    Hum Immunol; 1986 Oct; 17(2):94-101. PubMed ID: 2428786
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immune functions in healthy blood donors with HLA-DW2 and -DW3 antigens.
    Ilonen J; Salonen R; Hyypiä T; Lankinen K; Karttunen R; Salmi A
    Immunobiology; 1986 Jul; 171(4-5):388-99. PubMed ID: 3488954
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Two distinct class II molecules encoded by the genes within HLA-DR subregion of HLA-Dw2 and Dw12 can act as stimulating and restriction molecules.
    Sone T; Tsukamoto K; Hirayama K; Nishimura Y; Takenouchi T; Aizawa M; Sasazuki T
    J Immunol; 1985 Aug; 135(2):1288-98. PubMed ID: 3159789
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Both DR and MT class II HLA molecules may restrict proliferative T-lymphocyte responses to antigen.
    Berle EJ; Thorsby E
    Scand J Immunol; 1982 Dec; 16(6):543-7. PubMed ID: 6186016
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Studies on human epidermal langerhans cells. IV. HLA-D restriction of langerhans cell-dependent antigen activation of T lymphocytes.
    Braathen LR; Thorsby E
    Scand J Immunol; 1982 Jan; 15(1):55-61. PubMed ID: 6176017
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lymphocyte blast transformation responses and viral antibodies in relation to HLA antigens in multiple sclerosis.
    Ilonen J; Reunanen M; Salmi A; Tiilikainen A
    J Neurol Sci; 1981 Jan; 49(1):117-33. PubMed ID: 6259296
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human rheumatoid synovial and normal blood dendritic cells as antigen presenting cell--comparison with autologous monocytes.
    Waalen K; Førre O; Teigland J; Natvig JB
    Clin Exp Immunol; 1987 Oct; 70(1):1-9. PubMed ID: 2826055
    [TBL] [Abstract][Full Text] [Related]  

  • 8. T cell clones restricted to "hybrid" HLA-D antigens?
    Hansen GS; Svejgaard A; Claësson MH
    J Immunol; 1982 Jun; 128(6):2497-9. PubMed ID: 6176640
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dw subtypes of serologically defined DR-DQ specificities restrict recognition of cytomegalovirus.
    Linner KM; Monroy C; Bach FH; Gehrz RC
    Hum Immunol; 1986 Oct; 17(2):79-86. PubMed ID: 2428785
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Involvement of class II HLA molecules in T cell activation by antigen. Implications for the autologous mixed lymphocyte reaction.
    Thorsby E; Berle E; Scott H; Braathen LR
    Behring Inst Mitt; 1983 May; (72):129-34. PubMed ID: 6100471
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HLA-D/DR restriction of proliferative T cell responses to antigen. Enrichment of antigen-specific T cell blasts and evidence of preferential HLA-D/DR restriction.
    Berle EJ; Thoresen AB; Thorsby E
    Tissue Antigens; 1982 Nov; 20(5):380-8. PubMed ID: 6186050
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of PPD-specific T-cell lines generated in type I (insulin-dependent) diabetic and healthy individuals.
    Mølvig J; Sønderstrup McDevitt G; Thomsen M; Bosmann B; Blangero C; de Preval C; Baek L; Nerup J
    Scand J Immunol; 1989 Nov; 30(5):615-29. PubMed ID: 2587937
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HLA-DR-, MB- and novel DC-related determinants restrict purified protein derivative of tuberculin (PPD)-stimulated human T cell proliferation.
    Pawelec G; Schneider EM; Müller C; Wernet P
    Eur J Immunol; 1985 Jan; 15(1):12-7. PubMed ID: 2578396
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Migration inhibition factor secreting human T-cell lines reactive to PPD: a study of their antigen specificity, MHC restriction and the use of Epstein-Barr virus-transformed B-cell lines as requirement for antigen-presenting cells.
    Vyakarnam A; Lachmann PJ
    Immunology; 1984 Dec; 53(4):601-10. PubMed ID: 6209204
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HLA-D restriction of antigen-specific proliferative T cell responses. Inhibitory activity of antisera against HLA determinants or stimulatory antigen.
    Thorsby E; Ferrone S; Nousiainen H; Hirschberg H
    Tissue Antigens; 1983 Feb; 21(2):148-58. PubMed ID: 6189261
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antigen presentation in an HLA-DR-restricted fashion by B-cell chronic lymphocytic leukemia cells.
    Yasukawa M; Shiroguchi T; Inatsuki A; Kobayashi Y
    Blood; 1988 Jul; 72(1):102-8. PubMed ID: 2455565
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clonal distribution of human T cells recognizing PPD in the context of each of two distinct Ia molecules.
    Koide Y; Yoshida TO
    Hum Immunol; 1984 Aug; 10(4):203-12. PubMed ID: 6088445
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interferon-gamma production in response to in vitro stimulation with collagen type II in rheumatoid arthritis is associated with HLA-DRB1(*)0401 and HLA-DQ8.
    Berg L; Rönnelid J; Sanjeevi CB; Lampa J; Klareskog L
    Arthritis Res; 2000; 2(1):75-84. PubMed ID: 11219392
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antigen presentation by adherent cells from human peripheral blood. Correlation between T-cell activation and expression of HLA-DQ and -DR antigens.
    Nunez G; Ball EJ; Stastny P
    Hum Immunol; 1987 May; 19(1):29-39. PubMed ID: 3495523
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Human epidermal Langerhans cells are more potent than blood monocytes in inducing some antigen-specific T-cell responses.
    Braathen LR; Thorsby E
    Br J Dermatol; 1983 Feb; 108(2):139-46. PubMed ID: 6186267
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.